Clopidogrel Loading Dose Adjustment According to Platelet Reactivity Monitoring in Patients Carrying the 2C19*2Loss of Function Polymorphism
Authors:
- Laurent BonelloLBLaurent Bonello
- Sébastien ArmeroSASébastien Armero
- Omar Ait MokhtarOMOmar Ait Mokhtar
- Julien ManciniJMJulien Mancini
- Philippe AldebertPAPhilippe Aldebert
- Noémie SautNSNoémie Saut
- Nathalie BonelloNBNathalie Bonello
- Paul BarraganPBPaul Barragan
- Stéphane ArquesSAStéphane Arques
- Marie-Paule GiacomoniMGMarie-Paule Giacomoni
- Caroline Bonello-BurignatCBCaroline Bonello-Burignat
- Marie-Noelle BartholomeiMBMarie-Noelle Bartholomei
- 1 November 2010
- Vol. 56 (20) , 1630-1636
Abstract
No abstract availableKeywords
Funding Information
- Assistance Publique-Hopitaux de Marseille
This publication has 26 references indexed in Scilit:
- Consensus and Future Directions on the Definition of High On-Treatment Platelet Reactivity to Adenosine DiphosphateJACC, 2010
- Prognostic significance of post-clopidogrel platelet reactivity assessed by a point-of-care assay on thrombotic events after drug-eluting stent implantationEuropean Heart Journal, 2008
- Platelet Function Monitoring in Patients With Coronary Artery DiseaseJACC, 2007
- Impact of Platelet Reactivity After Clopidogrel Administration on Drug-Eluting Stent ThrombosisJACC, 2007
- Vasodilator‐stimulated phosphoprotein phosphorylation analysis prior to percutaneous coronary intervention for exclusion of postprocedural major adverse cardiovascular eventsJournal of Thrombosis and Haemostasis, 2007
- Évaluation de la réponse plaquettaire au clopidogrel au cours des syndromes coronariens. Comparaison de l'agrégométrie à l'ADP et de la méthode VASPAnnales de Cardiologie et d'Angéiologie, 2007
- ADP-induced platelet aggregation and platelet reactivity index VASP are good predictive markers for clinical outcomes in non-ST elevation acute coronary syndromeThrombosis and Haemostasis, 2007
- The significance of vasodilator-stimulated phosphoprotein for risk stratification of stent thrombosisThrombosis and Haemostasis, 2007
- Cytochrome P450 2C19 loss-of-function polymorphism is a major determinant of clopidogrel responsiveness in healthy subjectsBlood, 2006
- Clopidogrel Effect on Platelet REactivity in Patients With Stent ThrombosisJACC, 2005